Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruzhen Li

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Thoracic Cancer|August 30, 2025
Advances in the Application of Three-Dimensional Reconstruction in Thoracic Surgery: A Comprehensive ReviewGuihu Lin, Ruzhen Li, Xiao Li, et al.
Journal of Oncology|November 1, 2022
IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK PathwayRuzhen Li, Zhaohui Han, Wei Ma, et al.
Translational Lung Cancer Research|October 17, 2022
<i>PTS</i> is activated by <i>ATF4</i> and promotes lung adenocarcinoma development via the Wnt pathwayWei Ma, Chao Wang, Ruzhen Li, et al.
Biomaterials|April 18, 2026
Ionic immune checkpoint blockade through potassium-scavenging hydrogel to potentiate CD8<sup>+</sup> T cell-mediated cancer immunotherapyYang Liu, Xu Zhou, Weilin Li, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Thoracic Cancer|August 30, 2025
Advances in the Application of Three-Dimensional Reconstruction in Thoracic Surgery: A Comprehensive ReviewGuihu Lin, Ruzhen Li, Xiao Li, et al.
Journal of Oncology|November 1, 2022
IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK PathwayRuzhen Li, Zhaohui Han, Wei Ma, et al.
Translational Lung Cancer Research|October 17, 2022
<i>PTS</i> is activated by <i>ATF4</i> and promotes lung adenocarcinoma development via the Wnt pathwayWei Ma, Chao Wang, Ruzhen Li, et al.
Biomaterials|April 18, 2026
Ionic immune checkpoint blockade through potassium-scavenging hydrogel to potentiate CD8<sup>+</sup> T cell-mediated cancer immunotherapyYang Liu, Xu Zhou, Weilin Li, et al.
Pageof 1